AgeX Therapeutics Inc logo

AgeX Therapeutics Inc

NEW
FRA:0X40 (USA)  
€ 17.44 (0%) Mar 26
At Loss
Market Cap:
€ 25.61M ($ 29.20M)
Enterprise V:
€ 29.32M ($ 33.43M)
Volume:
-
Avg Vol (2M):
-
Trade In:
What is a stock summary page? Click here for an overview.

Business Description

Description
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.
Name Current Vs Industry Vs History
Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -48.29
12-1 Month Momentum % -48.29

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
FCF Margin % -5522.9
Name Current Vs Industry Vs History

Financials (Next Earnings Date:2025-05-31 Est.)

FRA:0X40's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

AgeX Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.131
EPS (TTM) (€) -12.779
Beta -
3-Year Sharpe Ratio -0.13
3-Year Sortino Ratio -0.21
Volatility % 53.77
14-Day RSI -
14-Day ATR (€) 0.763692
20-Day SMA (€) -
12-1 Month Momentum % -48.29
52-Week Range (€) 10.058619 - 23.563899
Shares Outstanding (Mil) 2.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AgeX Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

AgeX Therapeutics Inc Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

AgeX Therapeutics Inc Frequently Asked Questions

What is AgeX Therapeutics Inc(FRA:0X40)'s stock price today?
The current price of FRA:0X40 is €17.44. The 52 week high of FRA:0X40 is €23.56 and 52 week low is €10.06.
When is next earnings date of AgeX Therapeutics Inc(FRA:0X40)?
The next earnings date of AgeX Therapeutics Inc(FRA:0X40) is 2025-05-31 Est..
Does AgeX Therapeutics Inc(FRA:0X40) pay dividends? If so, how much?
AgeX Therapeutics Inc(FRA:0X40) does not pay dividend.

Press Release

Subject Date
No Press Release